Filter Your Search

Clinical Trial Search

Keyword

Principal Investigator

Condition/Disease

For Healthcare Professionals

At Henry Ford Health System we serve a triple mission of Clinical Care, Research and Education. It is this triple mission that drives how we care for our patients, how we interact with referring physicians, how we work to innovate healthcare and how we train future physicians.

Learn More

Clinical Trials Search Results

Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of treatment of Pruritus in Patients With Primary Biliary Cholangitis (PBC)

Principal Investigator:Stuart C Gordon, MD

Status: Open

Contact Phone: (313) 916-8423

Contact Email: GIHepatotogyClinicalTrials@hfhs.org

PCYC-1128-CA: A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors

Principal Investigator:Ding Wang, MD

Status: Accepting Participants

Contact Phone: (313) 916-7453

Contact Email: CTOResearch@hfhs.org

PCYC-1128-CA: A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors

Principal Investigator:Ding Wang, MD

Status: Accepting Participants

Contact Phone: (313) 916-7453

Contact Email: CTOResearch@hfhs.org

A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Therapy in Patients With Diabetic Gastroparesis

Principal Investigator:Eva H Alsheik, MD

Status: Open

Contact Phone: (313) 916-8423

Contact Email: GIHepatologyClinicalTrials@hfhs.org

A 3-Part Adaptive Design Study to Assess Safety, Tolerability and Efficacy of Treatment in Patients with Non-alcoholic Steatohepatitis (NASH)

Principal Investigator:Kimberly A Brown, MD

Status: Open

Contact Phone: (313) 916-8423

Contact Email: GIHepatologyClinicalTrials@hfhs.org

A Comparison Study Of Implanted Disolving Investigational Sustained Relased Ocular Medication To Standard Of Care Treatment Procedure For Patients With Open Angle Glaucoma Or Ocular Hypertension

Principal Investigator:David A Crandall, MD

Status: Accepting Participants

Contact Phone: (313) 916-8500

Contact Email: EyeTrials@hfhs.org

A Double-Blind, Placebo-Controlled Proof-of-Concept Study Evaluating Therapy in Patients with Primary Biliary Cholangitis (PBC) Who Have an Inadequate Response or Are Intolerant of UDCA

Principal Investigator:Stuart C Gordon, MD

Status: Open

Contact Phone: 313-916-8423

Contact Email: GIHepatologyClinicalTrials@hfhs.org

A Multi-Center Comparison Study Involving Intravitreal Injections for Central-Involved Diabetic Macular Edema sponsored by Diabetic Retinopathy Clinical Research Network sponsored by the NIH

Principal Investigator:Paul A Edwards, MD

Status: Accepting Participants

Contact Phone: (313) 916-8500

Contact Email: EyeTrials@hfhs.org

A Multi-Center Open-Label Phase 1/2 Study of BGB324 in Combination with Erlotinib in Patients with Stage IIIb or Stage IV Non-Small Cell Lung Cancer (BGBC004)

Principal Investigator:Igor I Rybkin, MD

Status: Accepting Participants

Contact Phone: (313) 916-7453

Contact Email: TOCtrials@hfhs.org

A Multi-center, Randomized, Sham-controlled, Double-blind, Ascending-dose Study of SBI-101 Therapy in Subjects with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy

Principal Investigator:Kausik Umanath, MD

Status: Accepting Participants

Contact Phone: (313) 916-7103

Contact Email: NephrologyResearch@hfhs.org

Page 1 of 32 | Results 1 - 10 of 313

Featured Locations Search All Locations

Browse Locations by Type

Frequently Searched ServicesSearch All Services

Browse Services by A-Z

Log in to MyChart

Henry Ford Health System

Resources

Research & Education

Clinical Trial Search

For Healthcare Professionals

Clinical Trials Search Results

Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of treatment of Pruritus in Patients With Primary Biliary Cholangitis (PBC)

PCYC-1128-CA: A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors

PCYC-1128-CA: A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal And Genitourinary Tumors

A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Therapy in Patients With Diabetic Gastroparesis

A 3-Part Adaptive Design Study to Assess Safety, Tolerability and Efficacy of Treatment in Patients with Non-alcoholic Steatohepatitis (NASH)

A Comparison Study Of Implanted Disolving Investigational Sustained Relased Ocular Medication To Standard Of Care Treatment Procedure For Patients With Open Angle Glaucoma Or Ocular Hypertension

A Double-Blind, Placebo-Controlled Proof-of-Concept Study Evaluating Therapy in Patients with Primary Biliary Cholangitis (PBC) Who Have an Inadequate Response or Are Intolerant of UDCA

A Multi-Center Comparison Study Involving Intravitreal Injections for Central-Involved Diabetic Macular Edema sponsored by Diabetic Retinopathy Clinical Research Network sponsored by the NIH

A Multi-Center Open-Label Phase 1/2 Study of BGB324 in Combination with Erlotinib in Patients with Stage IIIb or Stage IV Non-Small Cell Lung Cancer (BGBC004)

A Multi-center, Randomized, Sham-controlled, Double-blind, Ascending-dose Study of SBI-101 Therapy in Subjects with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy